GL
ELV icon

Graypoint LLC’s Elevance Health ELV Stock Holding History

Graypoint LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$748K Sell
1,924
-304
-14% -$122K 0.04% 258
2025
Q1 		$969K Buy
2,228
+658
+42% +$264K 0.06% 206
2024
Q4 		$579K Sell
1,570
-1,161
-43% -$486K 0.04% 278
2024
Q3 		$1.42M Buy
2,731
+256
+10% +$137K 0.09% 150
2024
Q2 		$1.34M Buy
2,475
+247
+11% +$131K 0.09% 148
2024
Q1 		$1.16M Buy
2,228
+247
+12% +$123K 0.08% 165
2023
Q4 		$934K Buy
1,981
+297
+18% +$137K 0.08% 174
2023
Q3 		$733K Buy
1,684
+193
+13% +$87.5K 0.07% 183
2023
Q2 		$662K Sell
1,491
-124
-8% -$57.2K 0.07% 181
2023
Q1 		$742K Buy
1,615
+536
+50% +$255K 0.08% 159
2022
Q4 		$554K Sell
1,079
-6
-0.6% -$3.05K 0.07% 178
2022
Q3 		$493K Buy
1,085
+358
+49% +$171K 0.06% 187
2022
Q2 		$351K Buy
727
+258
+55% +$128K 0.05% 225
2022
Q1 		$231K Buy
469
+31
+7% +$14.2K 0.02% 300
2021
Q4 		$203K Buy
+438
New +$184K 0.02% 292

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Graypoint LLC's ELV Position: Q2 2025 in Review

Graypoint LLC reduced its Elevance Health (ELV) stake by 14% in Q2 2025, selling an estimated $122K and leaving 1,924 shares worth $748K. The position accounts for 0.04% of the portfolio, ranked #258.

Graypoint LLC first reported a position in ELV in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.42M in Q3 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Graypoint LLC held 1,924 shares of Elevance Health worth $748K as of Q2 2025.
  • Graypoint LLC sold 304 Elevance Health shares in Q2 2025, an estimated $122K.
  • Elevance Health made up 0.04% of Graypoint LLC's portfolio in Q2 2025, its #258 holding.
  • Graypoint LLC first reported a position in Elevance Health in Q4 2021 and has held it in 15 quarters since.
  • Graypoint LLC's Elevance Health position peaked at $1.42M in Q3 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.